The IL-5 inhibitor is already available under the Fasenra brand name for maintenance use in severe eosinophilic asthma, but a new study conducted by researchers at King's College London (KCL ...

Fasenra is already approved as an add-on maintenance treatment for severe eosinophilic asthma, making $1.3 billion in sales last year. It is also being developed for other indications including ...

Severe eosinophilic is effectively treated with benralizumab, with especially good outcomes in patients with high BEC and high FeNO.

"Recent research highlights the critical role of various immune cells in the pathogenesis of asthma, particularly T helper type 2 (Th2) cells, innate lymphoid cells type 2 (ILC2s), eosinophils ...

15, 2025 — Researchers have made an important discovery in the field of asthma research ... identified one of the allergens responsible for eosinophilic esophagitis (EoE), an inflammatory ...

Eosinophilic gastroenteritis (EGE) is characterized by dense eosinophilic inflammation of one or several digestive tract sections. The symptoms include abdominal pain, weight loss, vomiting and ...

This is the first major breakthrough in 50 years. British researchers have just discovered a new treatment for severe forms ...

Eosinophils have long been regarded as a key inflammatory cell mediator in the pathogenesis of asthma, although their exact role is unclear. Downregulation of eosinophil activity via targeted ...